Does the media prefer HIMS or GH?

In the previous week, Hims & Hers Health had 1 more articles in the media than Guardant Health. MarketBeat recorded 12 mentions for Hims & Hers Health and 11 mentions for Guardant Health. Hims & Hers Health's average media sentiment score of 0.77 beat Guardant Health's score of 0.06 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 2 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to HIMS or BTSG?

In the previous week, BrightSpring Health Services had 1 more articles in the media than Hims & Hers Health. MarketBeat recorded 13 mentions for BrightSpring Health Services and 12 mentions for Hims & Hers Health. BrightSpring Health Services' average media sentiment score of 0.84 beat Hims & Hers Health's score of 0.77 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive BrightSpring Health Services 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer HIMS or FMS?

In the previous week, Hims & Hers Health had 10 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 12 mentions for Hims & Hers Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.90 beat Hims & Hers Health's score of 0.77 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fresenius Medical Care AG & Co. KGaA 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger valuation and earnings, HIMS or PACS?

PACS Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hims & Hers Health $2.35B 3.78 $128.37M -$0.09 N/A PACS Group $5.29B 1.34 $191.54M $1.56 28.64

Does the media refer more to HIMS or PACS?

In the previous week, Hims & Hers Health had 1 more articles in the media than PACS Group. MarketBeat recorded 12 mentions for Hims & Hers Health and 11 mentions for PACS Group. Hims & Hers Health's average media sentiment score of 0.77 beat PACS Group's score of 0.04 indicating that Hims & Hers Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PACS Group 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to CAI or HIMS?

In the previous week, Hims & Hers Health had 8 more articles in the media than Caris Life Sciences. MarketBeat recorded 12 mentions for Hims & Hers Health and 4 mentions for Caris Life Sciences. Hims & Hers Health's average media sentiment score of 0.77 beat Caris Life Sciences' score of 0.50 indicating that Hims & Hers Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Caris Life Sciences 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Hims & Hers Health 6 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Hims & Hers Health (HIMS) Competitors

$38.34 +1.54 (+4.18%)

Closing price 03:59 PM Eastern

Extended Trading

$38.15 -0.19 (-0.50%)

As of 07:59 PM Eastern

Compare

HIMS vs. GH, BTSG, FMS, PACS, and CAI

Should you buy Hims & Hers Health stock or one of its competitors? MarketBeat compares Hims & Hers Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Hims & Hers Health include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), PACS Group (PACS), and Caris Life Sciences (CAI). These companies are all part of the "healthcare" industry.

How does Hims & Hers Health compare to Guardant Health?

Hims & Hers Health (NYSE:HIMS) and Guardant Health (NASDAQ:GH) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

Hims & Hers Health has higher revenue and earnings than Guardant Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.78	$128.37M	-$0.09	N/A
Guardant Health	$982.02M	22.80	-$416.28M	-$3.39	N/A

Hims & Hers Health has a beta of 2.35, indicating that its stock price is 135% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.59, indicating that its stock price is 59% more volatile than the broader market.

63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 5.6% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Hims & Hers Health had 1 more articles in the media than Guardant Health. MarketBeat recorded 12 mentions for Hims & Hers Health and 11 mentions for Guardant Health. Hims & Hers Health's average media sentiment score of 0.77 beat Guardant Health's score of 0.06 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	6 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Guardant Health	2 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Hims & Hers Health has a net margin of -0.56% compared to Guardant Health's net margin of -40.10%. Hims & Hers Health's return on equity of 6.10% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Guardant Health	-40.10%	N/A	-26.42%

Hims & Hers Health presently has a consensus target price of $30.63, suggesting a potential downside of 20.10%. Guardant Health has a consensus target price of $150.91, suggesting a potential downside of 10.61%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts plainly believe Guardant Health is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	23 Buy rating(s)	1 Strong Buy rating(s)	2.96

Summary

Hims & Hers Health beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to BrightSpring Health Services?

Hims & Hers Health (NYSE:HIMS) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, profitability, institutional ownership, valuation and earnings.

Hims & Hers Health presently has a consensus price target of $30.63, indicating a potential downside of 20.10%. BrightSpring Health Services has a consensus price target of $63.67, indicating a potential downside of 9.77%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, analysts plainly believe BrightSpring Health Services is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	16 Buy rating(s)	2 Strong Buy rating(s)	3.11

BrightSpring Health Services has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.78	$128.37M	-$0.09	N/A
BrightSpring Health Services	$12.91B	1.08	$190.67M	$1.41	50.04

BrightSpring Health Services has a net margin of 2.27% compared to Hims & Hers Health's net margin of -0.56%. BrightSpring Health Services' return on equity of 14.63% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
BrightSpring Health Services	2.27%	14.63%	4.41%

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, BrightSpring Health Services had 1 more articles in the media than Hims & Hers Health. MarketBeat recorded 13 mentions for BrightSpring Health Services and 12 mentions for Hims & Hers Health. BrightSpring Health Services' average media sentiment score of 0.84 beat Hims & Hers Health's score of 0.77 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	6 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	6 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has a beta of 2.35, meaning that its share price is 135% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.79, meaning that its share price is 79% more volatile than the broader market.

Summary

BrightSpring Health Services beats Hims & Hers Health on 13 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Hims & Hers Health (NYSE:HIMS) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Hims & Hers Health's net margin of -0.56%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Fresenius Medical Care AG & Co. KGaA	4.88%	8.90%	4.05%

Hims & Hers Health has a beta of 2.35, indicating that its share price is 135% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, indicating that its share price is 22% less volatile than the broader market.

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Hims & Hers Health had 10 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 12 mentions for Hims & Hers Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.90 beat Hims & Hers Health's score of 0.77 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	6 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.78	$128.37M	-$0.09	N/A
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.57	$1.11B	$1.90	12.43

Hims & Hers Health currently has a consensus target price of $30.63, suggesting a potential downside of 20.10%. Fresenius Medical Care AG & Co. KGaA has a consensus target price of $28.00, suggesting a potential upside of 18.54%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	4 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.44

Summary

Fresenius Medical Care AG & Co. KGaA beats Hims & Hers Health on 9 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to PACS Group?

Hims & Hers Health (NYSE:HIMS) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Comparatively, 70.1% of PACS Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

PACS Group has higher revenue and earnings than Hims & Hers Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.78	$128.37M	-$0.09	N/A
PACS Group	$5.29B	1.34	$191.54M	$1.56	28.64

PACS Group has a net margin of 4.49% compared to Hims & Hers Health's net margin of -0.56%. PACS Group's return on equity of 26.47% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
PACS Group	4.49%	26.47%	4.36%

In the previous week, Hims & Hers Health had 1 more articles in the media than PACS Group. MarketBeat recorded 12 mentions for Hims & Hers Health and 11 mentions for PACS Group. Hims & Hers Health's average media sentiment score of 0.77 beat PACS Group's score of 0.04 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	6 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	3 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Hims & Hers Health currently has a consensus price target of $30.63, suggesting a potential downside of 20.10%. PACS Group has a consensus price target of $48.00, suggesting a potential upside of 7.42%. Given PACS Group's stronger consensus rating and higher probable upside, analysts plainly believe PACS Group is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Hims & Hers Health has a beta of 2.35, indicating that its share price is 135% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, indicating that its share price is 108% less volatile than the broader market.

Summary

PACS Group beats Hims & Hers Health on 11 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

63.5% of Hims & Hers Health shares are held by institutional investors. 50.0% of Caris Life Sciences shares are held by company insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Caris Life Sciences currently has a consensus target price of $26.11, suggesting a potential upside of 46.61%. Hims & Hers Health has a consensus target price of $30.63, suggesting a potential downside of 20.10%. Given Caris Life Sciences' stronger consensus rating and higher possible upside, equities research analysts clearly believe Caris Life Sciences is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13

Caris Life Sciences has a net margin of 3.75% compared to Hims & Hers Health's net margin of -0.56%. Caris Life Sciences' return on equity of 98.28% beat Hims & Hers Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Hims & Hers Health	-0.56%	6.10%	1.52%

In the previous week, Hims & Hers Health had 8 more articles in the media than Caris Life Sciences. MarketBeat recorded 12 mentions for Hims & Hers Health and 4 mentions for Caris Life Sciences. Hims & Hers Health's average media sentiment score of 0.77 beat Caris Life Sciences' score of 0.50 indicating that Hims & Hers Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Caris Life Sciences	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	6 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Hims & Hers Health has higher revenue and earnings than Caris Life Sciences. Hims & Hers Health is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	6.20	-$68.09M	-$7.61	N/A
Hims & Hers Health	$2.35B	3.78	$128.37M	-$0.09	N/A

Summary

Caris Life Sciences beats Hims & Hers Health on 8 of the 14 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIMS vs. The Competition

Export

Metric	Hims & Hers Health	MEDICAL INFO SYS Industry	Medical Sector	NYSE Exchange
Market Cap	$8.52B	$1.86B	$6.92B	$23.62B
Dividend Yield	N/A	N/A	2.66%	3.98%
P/E Ratio	-425.99	82.48	27.35	31.58
Price / Sales	3.78	7.48	507.73	177.78
Price / Cash	43.97	26.08	29.65	18.69
Price / Book	16.11	5.83	11.06	4.83
Net Income	$128.37M	-$54.76M	$3.57B	$1.07B
7 Day Performance	14.94%	5.66%	2.56%	0.72%
1 Month Performance	46.03%	5.53%	7.39%	3.64%
1 Year Performance	-19.99%	1.55%	34.13%	18.34%

Hims & Hers Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIMS Hims & Hers Health	2.6302 of 5 stars	$38.34 +4.2%	$30.63 -20.1%	-23.3%	$8.52B	$2.35B	N/A	2,442
GH Guardant Health	1.9978 of 5 stars	$139.04 +6.3%	$142.19 +2.3%	+234.3%	$18.43B	$982.02M	N/A	2,506	Analyst Forecast Gap Up
BTSG BrightSpring Health Services	3.8044 of 5 stars	$68.98 +3.2%	$61.27 -11.2%	+212.1%	$13.61B	$13.65B	48.94	23,500	Analyst Downgrade
FMS Fresenius Medical Care AG & Co. KGaA	4.5814 of 5 stars	$23.89 +0.8%	$28.00 +17.2%	-16.3%	$12.90B	$22.20B	12.57	1,488	Positive News
PACS PACS Group	2.4575 of 5 stars	$38.68 +3.5%	$48.00 +24.1%	+239.5%	$6.10B	$5.29B	24.71	47,455	Trending News Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HIMS) was last updated on 7/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hims & Hers Health (HIMS) Competitors

HIMS vs. GH, BTSG, FMS, PACS, and CAI

How does Hims & Hers Health compare to Guardant Health?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Hims & Hers Health compare to PACS Group?

Summary

How does Hims & Hers Health compare to Caris Life Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hims & Hers Health (HIMS) Competitors

HIMS vs. GH, BTSG, FMS, PACS, and CAI

How does Hims & Hers Health compare to Guardant Health?

Which has stronger valuation & earnings, HIMS or GH?

Which has more risk and volatility, HIMS or GH?

Do insiders & institutionals hold more shares of HIMS or GH?

Does the media prefer HIMS or GH?

Is HIMS or GH more profitable?

Do analysts prefer HIMS or GH?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Do analysts prefer HIMS or BTSG?

Which has better valuation & earnings, HIMS or BTSG?

Is HIMS or BTSG more profitable?

Do insiders & institutionals believe in HIMS or BTSG?

Does the media refer more to HIMS or BTSG?

Which has more risk and volatility, HIMS or BTSG?

Summary

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Is HIMS or FMS more profitable?

Which has more volatility and risk, HIMS or FMS?

Do institutionals and insiders have more ownership in HIMS or FMS?

Does the media prefer HIMS or FMS?

Which has better valuation and earnings, HIMS or FMS?

Do analysts rate HIMS or FMS?

Summary

How does Hims & Hers Health compare to PACS Group?

Do institutionals and insiders hold more shares of HIMS or PACS?

Which has stronger valuation and earnings, HIMS or PACS?

Is HIMS or PACS more profitable?

Does the media refer more to HIMS or PACS?

Do analysts prefer HIMS or PACS?

Which has more volatility and risk, HIMS or PACS?

Summary

How does Hims & Hers Health compare to Caris Life Sciences?

Do insiders & institutionals have more ownership in CAI or HIMS?

Do analysts rate CAI or HIMS?

Is CAI or HIMS more profitable?

Does the media refer more to CAI or HIMS?

Which has higher earnings & valuation, CAI or HIMS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools